Plavix europe approval

Pharma FiercePharma

Paris, France and Princeton, New Jersey Sanofi-aventis (EURONEXT: SAN, and NYSE: SNY) and Bristol-Myers Squibb (NYSE: BMY) announced today the European approval of their dual antiplatelet combination tablet Duo Plavin®/Duo Cover® (clopidogrel 75mg and acetylsalicylic acid 100mg or 75 mg) by the European Commission.

Plavix and Aspirin After Stent 8 Years Later –

This is a summary of the European public assessment report (EPAR) for Clopidogrel ratiopharm.

Pharma FiercePharma

Press Announcements - Food and Drug

This is a summary of the European public assessment report (EPAR) for Plavix.

European Medicines Agency - Find medicine - Clopidogrel ratiopharm

Duo Plavin®/Duo Cover® is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA).


Plavix europe approval:

Rating: 100 / 100

Overall: 90 Rates